Location: New York, NY
CIK: 0001884931 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $209M (91.9% shares, 8.1% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABUS | ARBUTUS BIOPHARMA CORP | 13,241,916 | $43.3M | 20.7% | $2.43 | +51.5% | COM | 03879J100 |
| ROIV | ROIVANT SCIENCES LTD | 2,391,000 | $28.29M | 13.5% | $10.09 | +17.1% | SHS | G76279101 |
| LQDA | LIQUIDIA CORPORATION | 1,987,245 | $23.37M | 11.2% | $11.17 | -2.1% | COM NEW | 53635D202 |
| GNW | GENWORTH FINL INC | 2,986,960 | $20.88M | 10.0% | $5.50 | +30.5% | COM SHS | 37247D106 |
| CDZI | CADIZ INC | 3,719,951 | $19.34M | 9.3% | $3.60 | 0.0% | COM NEW | 127537207 |
| JOYY | JOYY INC | 420,427 | $17.59M | 8.4% | $33.95 | — | ADS REPSTG COM A | 46591M109 |
| — | ENDEAVOR GROUP HLDGS INC | 500,000 | $15.64M | 7.5% | $28.56 | — | CL A COM | 29260Y109 |
| NN | NEXTNAV INC | 629,590 | $9.796M | 4.7% | $3.61 | +269.4% | COMMON STOCK | 65345N106 |
| GSL | GLOBAL SHIP LEASE INC NEW | 369,768 | $8.072M | 3.9% | $19.36 | +20.5% | COM CL A | Y27183600 |
| — | ESPERION THERPEUTICS INC NE | 8,000,000 | $7.77M | 3.7% | $0.75 | — | NOTE 4.000%11/1 | 29664WAB1 |
| — | SABRE GLBL INC | 5,000,000 | $4.938M | 2.4% | $0.93 | — | NOTE 4.000% 4/1 | 78573NAE2 |
| — | INNOVATE CORP | 12,218,000 | $4.157M | 2.0% | $0.51 | — | NOTE 7.500% 8/0 | 404139AG2 |
| — | MAIDEN HOLDINGS LTD | 1,997,005 | $3.375M | 1.6% | $2.08 | — | SHS | G5753U112 |
| VATE | INNOVATE CORP | 320,131 | $1.581M | 0.8% | $4.94 | +6.0% | COM NEW | 45784J303 |
| NNAVW | NEXTNAV INC | 100,880 | $579K | 0.3% | $1.42 | — | *W EXP 99/99/999 | 65345N114 |
| OPK | OPKO HEALTH INC | 134,490 | $198K | 0.1% | $1.30 | +17.9% | COM | 68375N103 |
| TRIB | TRINITY BIOTECH PLC | 81,902 | $72,090 | 0.0% | $2.04 | — | SPONS ADR NEW | 896438504 |
| AEAEW | ALTENERGY ACQUISITION CORP | 186,315 | $783 | 0.0% | $0.23 | — | *W EXP 10/29/202 | 02157M116 |